Deal Flow
Deal flow coverage: platform acquisitions, add-ons, buyouts, take-privates, secondary transactions, GP-led continuation vehicles, and strategic minority investments across private markets.
Roark Capital Eyes $2B IPO for Inspire Brands Portfolio Company
The private equity firm considers public offering for restaurant conglomerate owning Dunkin', Arby's, and Jimmy John's.
Purpose Brands Expands Orangetheory Fitness in Japan via 10-Year Deal
Purpose Brands announces a 10-year renewal agreement with ITS Co., Ltd. to grow Orangetheory Fitness to over 100 studios in Japan by 2034.
Premier Graphene Advances Industrial Hemp Import Permits in Mexico
Premier Graphene Inc. announces its affiliate has progressed industrial hemp import permits and licensing, enabling operations in Mexico.
PE Firms Target API Sector with String of Recent Transactions
Astorg, EQT, New Mountain Capital and TA Associates drive consolidation in active pharmaceutical ingredients market.
Mutares Divests European Logistics Provider inTime to Tawin Holdings
German-listed investment firm Mutares exits time-critical logistics platform inTime in strategic sale to Asia-based Tawin Holdings Group.
Littlejohn Backs Power Infrastructure Consultant GDS Associates
Private equity firm Littlejohn & Co invests in GDS Associates, a power infrastructure consulting firm led by president David Brian.
KKR Pursues UOB Asset Management Deal Amid GP-Stakes Investment Surge
KKR joins bidding for United Overseas Bank's asset management arm as alternative asset managers expand their capital-raising capabilities.
KKR Commits $235M to Korean Renewables Amid Geopolitical Market Volatility
Global PE giant KKR invests heavily in SK Eternix as climate strategies face stress testing from Middle East tensions and market uncertainty.
KALA BIO Announces AI Platform for Biotech and Pharma Sector
KALA BIO enters agreement with Younet AI to develop an on-premises AI infrastructure for secure biotech data analysis, addressing industry challenges.
JAKKS Pacific Renews Minecraft Costume Licensing Deal
Disguise, a division of JAKKS Pacific, extends its global licensing agreement for Minecraft costumes, building on the brand's growth amid recent media successes.
JAKKS Pacific and VIZ Media Partner on Naruto Toys and Costumes
JAKKS Pacific announces a licensing agreement with VIZ Media to produce Naruto action figures, playsets, and costumes for the US and Canada, set to debut in Spring 2027.
Hopewell Therapeutics Sublicenses LNPs to Foxcroft for Cancer Vaccine Development
Hopewell Therapeutics grants a global sublicense of its tissue-targeting LNPs to Foxcroft Therapeutics for novel cancer vaccines, including financial terms and planned collaborations.
Healthcare Manufacturing Draws $10B+ from Mega-Funds Amid Supply Chain Shift
Large PE funds pivot to pharmaceutical ingredients and medical components as sector consolidation accelerates post-pandemic.
Greenbelt Capital Portfolio Company Saber Power Acquires Bounds Construction
Houston-based electrical services firm Saber Power expands capabilities through strategic acquisition backed by Greenbelt Capital.
BlackPeak Exits euShipments.com Through Strategic Sale to Austrian Post
Private equity firm BlackPeak divests e-commerce logistics provider to Austrian postal service in strategic exit transaction.
Astorg Portfolio Company Executes Triple Acquisition Strategy
Solabia's simultaneous acquisition of three specialty chemical businesses signals PE-backed consolidation in niche industrial markets.
Arcline's Senior Aerospace Bid Signals PE Capital Deployment Pressure
US private equity firm Arcline Investment Management submits preliminary cash offer for UK aerospace manufacturer Senior amid competitive auction.
Blackstone and Ares Deploy $5B in Private Credit for Thoma Bravo Deal
Two credit giants finance Thoma Bravo's WWEX-Auctane merger, highlighting private credit's growing role in large buyouts.
Advent's $1.52bn Senior Aerospace Bid Rejection Signals Challenging Market
Advent International's failed takeover approach for UK aerospace supplier Senior highlights valuation gaps plaguing mid-market deals.
